ARMC
IDXX icon

American Research & Management Company’s Idexx Laboratories IDXX Stock Holding History

American Research & Management Company’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1
Closed – – 435
2022
Q2 		$0 Hold
1
– – ﹤0.01% 403
2022
Q1 		$1K Hold
1
– – ﹤0.01% 387
2021
Q4 		$1K Buy
+1
New +$628 ﹤0.01% 377

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

American Research & Management Company's IDXX Position: Q3 2022 in Review

American Research & Management Company sold out of Idexx Laboratories (IDXX) in Q3 2022, closing a stake of 1 share.

American Research & Management Company first reported a position in IDXX in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q1 2022. 925 funds tracked by Wall St. Rank hold IDXX as of Q3 2022.

  • American Research & Management Company reported no remaining Idexx Laboratories position as of Q3 2022 after selling out during the quarter.
  • American Research & Management Company sold 1 Idexx Laboratories share in Q3 2022.
  • American Research & Management Company first reported a position in Idexx Laboratories in Q4 2021 and held it in 3 quarters.
  • American Research & Management Company's Idexx Laboratories position peaked at $1K in Q1 2022.
  • 925 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.